• Testing Drug Quality Inexpensively - Chromatography Investigates

Testing Drug Quality Inexpensively - Chromatography Investigates

Jan 17 2019 Read 1305 Times

Substandard and falsified medical products may cause harm to patients and fail to treat the diseases for which they were intended’ is stated as one of the key facts in a recent World Health Organization (WHO) fact sheet. It is a problem that affects all regions of medicine and affects patients and health organizations around the globe. But it is a bigger problem in low- and middle-income countries (LMICs), where an estimated 1 in 10 medical products are substandard or falsified.

Researchers are developing methods to try and combat this practice, and a paper published in the Journal of Global Oncology - Paper Analytic Device to Detect the Presence of Four Chemotherapy Drugs - reports on a new device that could help in the detection of substandard or falsified chemotherapy drugs. Take a closer look at the issue and see how chromatography can play a role in developing new methods of detection.

Increasing demand for chemotherapy drugs

Demand for chemotherapy drugs in LMICs is increasing as more organizations commit time, effort and money in these regions in detecting and treating cancer. The researchers state that this increase in demand for chemotherapy drugs will create new opportunities for unethical manufacturers and distributors. It is a pattern that has been witnessed before when a program to reduce malarial deaths in Africa was rolled out.

Chemotherapy drugs are targets for falsification due to their high selling prices and low post-marketing monitoring in LMICs. The WHO define substandard and falsified as:

  • Substandard - these are authorized medical products that fail to meet either their quality standards or specifications, or both.
  • Falsified - medical products that deliberately/fraudulently misrepresent their identity, composition or source.

ChemoPAD - testing the drugs for APIs

One of the most common problems found in substandard or falsified anticancer drugs is the absence of an active pharmaceutical agent (API). In LMIC regions, this becomes an issue because of the difficulty in testing the quality of drugs using equipment found in laboratories in more developed countries. The paper referenced above reports on a paper pad- ChemoPAD - that has been developed to test for APIs in chemotherapy drugs.

To use the device, the user simply places a small sample of the drug on the application strip - a strip of absorbent paper. The card is simply folded over allowing the sample to impregnate the testing area - a portion of the card that is impregnated with reagents that will react with APIs in the sample. After simple processing, the user compares the colours obtained from the reaction between sample and reagents with a standard - they can see whether the drugs they are using are genuine or not.

The device is simply to use and gives a result in a few minutes. The device was validated using HPLC - a powerful and flexible method discussed in the article, Using Different HPLC Column Chemistries To Maximise Selectivity For Method Development.

Reader comments

Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.

Post a Comment

Digital Edition

Chromatography Today - June 2019

June 2019

In This Edition Fundamental Aspects - High-resolution MS coupled to Photoionisation - Why do you Need to Measure BTEX in Ambient Air? - Gas Chromatography - Vacuum Ultraviolet Spectroscopy...

View all digital editions


ACS National Meeting & Expo, Fall 2019

Aug 25 2019 San Diego, CA, USA

Microscopy Conference 2019

Sep 01 2019 Berlin, Germany

BMSS Annual Meeting

Sep 03 2019 Manchester, UK

ICMGP 2019

Sep 08 2019 Krakow, Poland

View all events